← All stocks

ARS Pharmaceuticals, Inc.

SPRY Net buying
CIK 0001671858 #3013 in the set updated 19 Sep 2026
Bought (120 mo)
$109.79M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$121.40M
$47.85M on a plan · $23.16M straight out of an exercise
Sold at will
$50.39M
23 of 223 sales
Net
−$11.62M
+$59.39M against sales at will

By person

25 insiders · 261 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$44.72M (6)
+$44.72M
9,958,073
$99.58M
Lowenthal Richard E
PRESIDENT AND CEO
$23.82M (73) scheduled
−$23.82M
5,523,683
$55.24M
Flynn James E
10% owner
$23.81M (10)
−$23.81M
4,887,254
$48.87M
−21.1%
Tanimoto Sarina
CHIEF MEDICAL OFFICER
$23.80M (74) scheduled
−$23.80M
4,680,959
$46.81M
ORBIMED ADVISORS LLC entity
Director
$28.10M (3)
$12.59M (5)
+$15.51M
8,740,888
$87.41M
+782.0%
Thompson Peter A.
Director
$28.10M (3)
$12.59M (5)
+$15.51M
8,740,888
$87.41M
+782.0%
Shawver Laura
Director
$8.63M (23) scheduled
−$8.63M
210,346
$2.10M
+163.3%
Chakma Justin
Chief Business Officer
$8.56M (13) scheduled
−$8.56M
0
$0.00
Schroeder Thilo
Director
$5.00M (1)
+$5.00M
1,910,029
$19.10M
ROOT JONATHAN D
Director
$2.04M (3)
+$2.04M
2,269,417
$22.69M
+4.5%
Dorsey Brian
Chief Operating Officer
$1.82M (5) scheduled
−$1.82M
10,789
$107.89K
0.0%
SAUNDERS BRENT L
Director
$1.71M (1) scheduled
−$1.71M
0
$0.00
Karas Eric
Chief Commercial Officer
$1.31M (8) scheduled
−$1.31M
12,176
$121.76K
0.0%
Scott Kathleen D.
Chief Financial Officer
$51.51K (1)
$1.29M (4) scheduled
−$1.24M
18,292
$182.92K
+82.2%
Fitzpatrick Alexander A
Chief Legal Officer
$319.95K (2)
$1.49M (2) scheduled
−$1.17M
90,910
$909.10K
+728.3%
Presidio Management Group XII, L.L.C. entity
10% owner
$1,000.00K (1)
+$1,000.00K
2,221,798
$22.22M
Piazza Jonathan
Chief Financial Officer
$249.98K (1)
+$249.98K
69,225
$692.25K
+2,809%
CAPPS VICKIE L
Director
$199.98K (1)
+$199.98K
61,576
$615.76K
+18.3%
Hawkinson Russ
Sr. Vice President of Finance
$5.00K (1)
+$5.00K
37,251
$372.51K
+3,062%
Shah Pratik
Director
4,474,554
$44.75M
Dadoo Rajeev
Director
3,009,677
$30.10M
Alexandria Venture Investments, LLC entity
10% owner
699,412
$6.99M
Kelly Michael
Director
83,225
$832.25K
Odegard Valerie
President and CSO
61,639
$616.39K
Hunder Naomi
Chief Medical Officer
54,427
$544.27K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Lowenthal Richard E
6 Dec 2024
PRESIDENT AND CEO
Exercised, kept indirect
11,876
$8.42
$100.00K
Lowenthal Richard E
6 Dec 2024
PRESIDENT AND CEO
Exercised, kept indirect
13,789
$1.44
$19.86K
Lowenthal Richard E
6 Dec 2024
PRESIDENT AND CEO
Exercised, kept
11,876
$8.42
$100.00K
Tanimoto Sarina
6 Dec 2024
CHIEF MEDICAL OFFICER
Exercised, kept indirect
11,876
$8.42
$100.00K
Tanimoto Sarina
6 Dec 2024
CHIEF MEDICAL OFFICER
Exercised, kept
11,876
$8.42
$100.00K
Tanimoto Sarina
6 Dec 2024
CHIEF MEDICAL OFFICER
Exercised, kept
13,789
$1.44
$19.86K
Lowenthal Richard E
23 Apr 2024
PRESIDENT AND CEO
Exercised, kept indirect
48,260
$1.44
$69.49K
Lowenthal Richard E
23 Apr 2024
PRESIDENT AND CEO
Exercised, kept indirect
82,733
$0.84
$69.50K
Tanimoto Sarina
23 Apr 2024
CHIEF MEDICAL OFFICER
Exercised, kept
48,260
$1.44
$69.49K
Tanimoto Sarina
23 Apr 2024
CHIEF MEDICAL OFFICER
Exercised, kept
82,733
$0.84
$69.50K
Lowenthal Richard E
19 Apr 2024
PRESIDENT AND CEO
Exercised, kept
69,444
$1.44
$100.00K
Lowenthal Richard E
19 Apr 2024
PRESIDENT AND CEO
Exercised, kept
119,047
$0.84
$100.00K
Tanimoto Sarina
19 Apr 2024
CHIEF MEDICAL OFFICER
Exercised, kept indirect
69,444
$1.44
$100.00K
Tanimoto Sarina
19 Apr 2024
CHIEF MEDICAL OFFICER
Exercised, kept indirect
119,047
$0.84
$100.00K
Shawver Laura
5 Aug 2022
Chief Executive Officer
Exercised, kept
78,740
$1.27
$100.00K
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 229
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020